Tag: cerebral vasospasm
Rapid Medical announces enrolment of final patient in post-market SUCCESS study
Rapid Medical has announced that the final patient has been enrolled in SUCCESS—a US Food and Drug Administration (FDA) post-market surveillance study assessing the...
Vesalio announces successful initial use of NeVa VS device in USA
Vesalio has announced the successful initial use of its NeVa VS device in the USA for the treatment of post-aneurysmal subarachnoid haemorrhage (aSAH) cerebral...
Vesalio announces US FDA approval of NeVa VS to treat cerebral...
Vesalio has announced US Food and Drug Administration (FDA) humanitarian device exemption (HDE) approval for commercialisation of its NeVa VS device, which is indicated...
Current literature suggests promise held by electrical stimulation therapies for cerebral...
Electrical stimulation technologies, and in particular spinal cord stimulation (SCS) and sphenopalatine ganglion stimulation, offer a promising adjunct to existing therapies for cerebral vasospasm...
Rapid Medical receives FDA Breakthrough Device designation for vasospasm treatment
Rapid Medical has announced US Food and Drug Administration (FDA) Breakthrough Device designation for its Comaneci embolisation assist technology, which is intended to facilitate the treatment of...
Rapid Medical receives CE mark for remodelling mesh device
Rapid Medical has announced that its adjustable remodelling mesh device, called Comaneci, has received CE mark approval. Comaneci is intended to treat cerebral vasospasm...
